1. HBW Insight
  2. >>Beauty
  3. >>Business

Five Reasons Why GSK Spinning Off Consumer Health Wouldn't Be Easy

 
• By Eleanor Malone

GSK once again provided grist to the stock market rumor mill recently with reports of its chairman talking to major shareholders about the possibility of splitting up the company. But there are reasons to doubt whether talks would lead to action any time soon.

Emma Walmsley GSK
GSK's CEO, Emma Walmsley • Source: GlaxoSmithKline

It's not the first time that investor disgruntlement has bubbled to the surface at GlaxoSmithKline PLC. If UK media reports are to be believed, major shareholders have been pushing the UK big pharma's chairman Philip Hampton to consider breaking up the company, something that had become a common refrain under the leadership of previous CEO Andrew Witty, culminating not only in Witty's departure in 2017 but also the withdrawal of high-profile fund manager Neil Woodford as a shareholder.

The argument for a break-up rests on GSK's lower-margin consumer business having a very different financial model from its pharmaceutical...

More from Business

More from Beauty

NIVEA’s ‘Milestone’ Launch Brings ‘Breakthrough’ Anti-Aging Tech To Masses

 
• By Eileen Francis

Beiersdorf is launching NIVEA Epigenetics Rejuvenating Serum with Epicelline, the biggest launch in its history. The range will debut first in Europe, reaching 30 countries by the end of 2025.

Producers Sue Oregon Over ‘Crushing’ EPR Recycling Law, Call It Unconstitutional

 
• By Eileen Francis

A national wholesalers’ trade group is suing Oregon, claiming its EPR law, which requires producers to register, report packaging data and pay fees, is unconstitutional and overly burdensome.

Aloette Beauty Referred To FTC For Failing To Participate In Self-Reg Forum Over Earnings Claims

 
• By Eileen Francis

Aloette Cosmetics will face the FTC for possible enforcement action after it failed to respond to multiple inquiries by the BBB National Program’s Direct Selling Self-Regulatory Council.